Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02384655Phase 2Unknown
Phase 2, open-label, single-arm trial, sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Change in daily volume of expressed milk at Day 14. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02384655.